Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,313
  • Shares Outstanding, K 27,471
  • Annual Sales, $ 19,610 K
  • Annual Income, $ -5,620 K
  • EBIT $ -6 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.37
  • Price/Sales 5.23
  • Price/Cash Flow N/A
  • Price/Book 3.45
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.02 on 05/13/25
  • Next Earnings Date 08/12/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Computers and Technology
  • INDUSTRY GROUPING Computer - Software

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.58 +8.10%
on 06/24/25
3.99 -3.01%
on 07/15/25
+0.04 (+1.04%)
since 06/16/25
3-Month
3.00 +29.00%
on 04/21/25
4.01 -3.61%
on 05/16/25
+0.80 (+26.06%)
since 04/16/25
52-Week
1.19 +225.21%
on 08/08/24
4.01 -3.61%
on 05/16/25
+2.50 (+182.48%)
since 07/16/24

Most Recent Stories

More News
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial...

BWAY : 17.85 (+0.73%)
HYFT : 1.9400 (+0.52%)
ICAD : 3.87 (+3.75%)
Cancer Surge Meets Funding Crunch as Breakthrough Biotechs Line Up Milestones in 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – More and more young women are getting diagnosed with cancer than ever before, causing many to sound the...

ONCY : 0.9768 (+3.40%)
CTXR : 1.2000 (+7.14%)
CTOR : 1.1600 (+6.42%)
ONC.TO : 1.42 (+2.16%)
RDNT : 75.85 (-0.41%)
ICAD : 3.87 (+3.75%)
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation...

RDNT : 75.85 (-0.41%)
ICAD : 3.87 (+3.75%)
iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.

ICAD : 3.87 (+3.75%)
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health

Issued on behalf of Avant Technologies Inc. Vancouver, BC – June 17, 2025 – USA News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...

MSFT : 492.02 (+0.20%)
AVAI : 0.3040 (+4.83%)
RXRX : 4.77 (-1.04%)
AMZN : 227.92 (+0.45%)
ICAD : 3.87 (+3.75%)
Capital Flows Shift From Research Labs to Pharmacy Counters—A Watershed Moment for AI Health

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...

MSFT : 492.02 (+0.20%)
AVAI : 0.3040 (+4.83%)
RXRX : 4.77 (-1.04%)
AMZN : 227.92 (+0.45%)
ICAD : 3.87 (+3.75%)
Icad: Q1 Earnings Snapshot

Icad: Q1 Earnings Snapshot

ICAD : 3.87 (+3.75%)
iCAD Reports Financial Results for First Quarter Ended March 31, 2025

ICAD : 3.87 (+3.75%)
Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators

/CNW/ -- USA News Group News Commentary – In a clear sign of growing confidence in artificial intelligence (AI) for healthcare, the U.S. Food and Drug...

MSFT : 492.02 (+0.20%)
AIDX.TO : 0.90 (-5.26%)
HWAIF : 0.6600 (+2.48%)
AVAI : 0.3040 (+4.83%)
RDNT : 75.85 (-0.41%)
ICAD : 3.87 (+3.75%)
Investors Are Watching Artificial Intelligence (AI) Reshape Diagnostics and Drug Discovery

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating....

MSFT : 492.02 (+0.20%)
AVAI : 0.3040 (+4.83%)
LNTH : 60.88 (-2.23%)
RDNT : 75.85 (-0.41%)
ICAD : 3.87 (+3.75%)

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

3rd Resistance Point 4.10
2nd Resistance Point 3.99
1st Resistance Point 3.93
Last Price 3.87
1st Support Level 3.76
2nd Support Level 3.65
3rd Support Level 3.59

See More

52-Week High 4.01
Last Price 3.87
Fibonacci 61.8% 2.94
Fibonacci 50% 2.60
Fibonacci 38.2% 2.27
52-Week Low 1.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar